BiographyRenée JG Arnold is currently Adjunct Associate Professor, Master of Public Health program, Department of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai, New York, New York, where she has developed and teaches the pharmacoeconomics coursework. She is also President & CEO, Arnold Consultancy & Technology, LLC, where she oversees outcomes research and develops affiliated software for pharmaceutical and government programs. Her special interest in evidence-based health derives from her research that deals with use of technology to collect and/or model real-world data for use in rational decision-making by healthcare practitioners and policy makers.
Dr. Arnold completed her undergraduate training at the University of Maryland and received her Doctor of Pharmacy degree from the University of Southern California in Los Angeles. She also completed a post-doctoral residency at University Hospital in San Diego/University of California at San Francisco School of Pharmacy. Dr. Arnold was previously VP, HEOR at Quorum Consulting, Inc./Navigant Consulting; Principal, IMS Health (IQVIA); and President and Co-Founder of Pharmacon International, Inc. Center for Health Outcomes Excellence.
Dr. Arnold is a founding member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and is the Chair of both the ISPOR Distance Learning Program and of the newly established ISPOR Open Source Models Special Interest Group. At no time have healthcare models been more relevant than the present, where many coronavirus forecasting models, sometimes with wildly diverging predictions, have been referenced for morbidity, mortality, and the like. The problem I and others see is that the code and inputs are unavailable to understand how these results were derived. The use of open source models (OSMs), those for which all data and programming associated with the model are made openly available to enhance transparency and, perhaps, facilitate replication and ongoing modifications of the model, have the potential to allow for faster access to critical knowledge. Use of OSMs, perhaps in an easily accessible database, could allow for a "crowdsourced" model review and more accurate/timely models, at least as far as the existing data allow.
Dr. Arnold is an author/co-author of numerous articles, book chapters and books in the areas of pharmacology, pharmacoeconomics and cost containment strategies and will shortly be releasing the 2nd edition of her pharmacoeconomics textbook.
Areas of Research / Professional Expertise
Her special interest in evidence-based health derives from her research that deals with use of technology to collect and/or model real-world data for use in rational decision making by healthcare practitioners and policy makers.
Use of modeling to assist in public health decision making.